Cell Design Labs Overview
- Founded
-
2015

- Status
-
Acquired/Merged
- Employees
-
8

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$472M
- Investors
-
1
Cell Design Labs General Information
Description
Developer of cell-based disruptive therapies designed to offer treatment for cancer and other devastating diseases. The company's therapies include disruptive T cell receptor therapies that modifies the body's immune cells to create therapeutic agents capable of selectively recognizing, disabling and destroying malignant threats, enabling medical researchers to develop cell-based therapies efficiently.
Contact Information
Primary Office
- 5858 Horton Street
- Suite 240
- Emeryville, CA 94608
- United States
Cell Design Labs Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 01-Dec-2017 | $472M | 000.00 | 00000 | Completed | Generating Revenue |
3. Later Stage VC (Series C) | 16-Jun-2016 | 000 | 000.00 | 0000 | Completed | Generating Revenue |
2. Early Stage VC (Series B) | 21-Dec-2015 | $22.9M | $30.7M | 000.00 | Completed | Generating Revenue |
1. Early Stage VC (Series A) | $7.8M | $7.8M | 000.00 | Completed | Generating Revenue |
Cell Design Labs Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 0,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
Series B | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A | 3,900,940 | $0.000100 | 6% | $2 | $2 | 1x | $2 | 24.12% |
Cell Design Labs Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cell-based disruptive therapies designed to offer treatment for cancer and other devastating diseases. The
Biotechnology
Emeryville, CA
8
As of 2016
000.00
0000
0000-00-00
000000&0
000.00
Cell Design Labs Competitors (75)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Carisma Therapeutics | Venture Capital-Backed | Philadelphia, PA | 00 | 00000 | 00000000000 | 00000 |
0000 000000 | Venture Capital-Backed | South San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
000000000 00000000 | Venture Capital-Backed | Newark, CA | 0 | 000.00 | 0000000000 0 | 000.00 |
000000000000000 | Venture Capital-Backed | Saint Louis, MO | 00 | 000.00 | 00000000000 | 000.00 |
000000 | Venture Capital-Backed | Utrecht, Netherlands | 00 | 00.000 | 0000000000 0 | 00.000 |
Cell Design Labs Patents
Cell Design Labs Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3755712-A1 | Chimeric transmembrane receptors and uses thereof | Pending | 21-Feb-2018 | 000000000 | |
US-20200384030-A1 | Chimeric transmembrane receptors and uses thereof | Pending | 21-Feb-2018 | 000000000 | |
US-20190194617-A1 | Single- and multi-chain chimeric antigen receptors | Pending | 22-Dec-2017 | 0000000000 | |
EP-3728322-A1 | Single- and multi-chain chimeric antigen receptors | Pending | 22-Dec-2017 | 0000000000 | |
US-20190194340-A1 | Methods of making bispecific anti-cd307e and anti-bcma chimeric antigen receptors and uses of the same | Pending | 29-Sep-2017 | C07K16/2878 |
Cell Design Labs Executive Team (6)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Wendell Lim Ph.D | Scientific Founder | ||
Gregory Giotta Ph.D | Senior Vice President Intellectual Property | ||
Fred Cohen Ph.D | Chairman & Co-Founder |
Cell Design Labs Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Fred Cohen Ph.D | Self | Chairman & Co-Founder | 000 0000 |
Cell Design Labs Signals
Cell Design Labs Former Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Arie Belldegrun | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Bellco Capital | Family Office | Minority | 000 0000 | 000000 0 | |
Brian Atwood | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Kleiner Perkins | Venture Capital | Minority | 000 0000 | 000000 0 | |
Mission Bay Capital | Venture Capital | Minority | 000 0000 | 000000 0 |